|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating expenses | |
| Research and development | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income (expense) | |
| Interest income | |
| Change in fair value of redeemable convertible preferred stock tranche liability | |
| Total other income (expense) | |
| Loss before income tax | |
| Income tax provision | |
| Net loss | |
| Comprehensive loss | |
| Net loss per share | |
| Weighted average common stock outstanding - basic (in shares) | |
| Weighted average common stock outstanding - diluted (in shares) | |
| Net loss per share of common stock - basic (in dollars per share) | |
| Net loss per share of common stock - diluted (in dollars per share) |
Loading...
